Skip to main content

Innovex International, Inc.

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

INVX$25.13+2.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)September 30,2026December 31,2025
Assets
Current assets
Cash and restricted cash$188,763$203,407
Trade receivables, net of allowance of $15,224 and $19,752 at September 30, 2026 and December 31, 2025, respectively251,825237,774
Contract assets2,2302,705
Inventories299,736248,433
Prepaid expenses and other current assets72,45035,728
Total current assets815,004728,047
Noncurrent assets
Property and equipment, net168,194158,874
Right-of-use assets – operating50,17752,204
Goodwill138,78099,720
Intangibles, net149,592116,230
Deferred tax asset, net83,134102,375
Other long-term assets10,13110,857
Total noncurrent assets600,008540,260
Total assets$1,415,012$1,268,307
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$82,336$60,711
Accrued expenses52,15249,148
Operating lease liabilities13,39712,670
Contract liabilities17,54911,986
Current portion of long-term debt and finance lease obligations5,8736,709
Other current liabilities12,8246,940
Total current liabilities184,131148,164
Noncurrent liabilities
Long-term debt and finance lease obligations18,27318,922
Operating lease liabilities37,52840,986
Deferred income taxes816500
Legal settlement accrual53,368—
Other long-term liabilities3,7792,036
Total noncurrent liabilities113,76462,444
Total liabilities$297,895$210,608
Commitments and contingencies (Note 16)
Stockholders’ equity
Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)$—$—
Common stock: $0.01 par value, 200,000,000 shares authorized at September 30, 2026 and December 31, 2025; 70,077,068 and 69,077,237 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively701691
Additional paid-in capital801,311767,650
Accumulated other comprehensive income9,3084,084
Retained earnings305,797285,274
Total stockholders’ equity$1,117,117$1,057,699
Total liabilities and stockholders’ equity$1,415,012$1,268,307
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.